Showing 1 to 3 of 3 results


Underdiagnosis of Alcohol Use Disorder in Spain
In Spain, thousands with alcohol use disorder (AUD) go undiagnosed in primary care due to systemic failures in detection, societal normalization of alcohol, and patient reluctance to disclose. Diagnostic tools exist, but underuse and stigma create significant barriers.
Underdiagnosis of Alcohol Use Disorder in Spain
In Spain, thousands with alcohol use disorder (AUD) go undiagnosed in primary care due to systemic failures in detection, societal normalization of alcohol, and patient reluctance to disclose. Diagnostic tools exist, but underuse and stigma create significant barriers.
Progress
32% Bias Score


Single CBD Dose Reduces Alcohol Cravings in AUD Study
A German study found that a single 800mg oral dose of CBD significantly reduced alcohol cravings and lowered activity in the brain's reward center among 28 individuals with alcohol use disorder (AUD), offering the first clinical evidence of CBD's potential in treating AUD.
Single CBD Dose Reduces Alcohol Cravings in AUD Study
A German study found that a single 800mg oral dose of CBD significantly reduced alcohol cravings and lowered activity in the brain's reward center among 28 individuals with alcohol use disorder (AUD), offering the first clinical evidence of CBD's potential in treating AUD.
Progress
20% Bias Score

Weekly Semaglutide Shows Promise in Reducing Alcohol Consumption
A JAMA Psychiatry study shows weekly semaglutide significantly reduced alcohol cravings and heavy drinking days in 48 adults with alcohol use disorder, with nearly 40% of the semaglutide group reporting no heavy drinking days in the final month versus 20% in the placebo group.

Weekly Semaglutide Shows Promise in Reducing Alcohol Consumption
A JAMA Psychiatry study shows weekly semaglutide significantly reduced alcohol cravings and heavy drinking days in 48 adults with alcohol use disorder, with nearly 40% of the semaglutide group reporting no heavy drinking days in the final month versus 20% in the placebo group.
Progress
40% Bias Score
Showing 1 to 3 of 3 results